These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 33387367)
1. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study. Agulló L; Aguado I; Muriel J; Margarit C; Gómez A; Escorial M; Sánchez A; Fernández A; Peiró AM Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445931 [TBL] [Abstract][Full Text] [Related]
3. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms. Ruano G; Kost JA Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992 [TBL] [Abstract][Full Text] [Related]
4. Pain polymorphisms and opioids: An evidence based review. Vieira CMP; Fragoso RM; Pereira D; Medeiros R Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275 [TBL] [Abstract][Full Text] [Related]
5. A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors. Zhao Q; Sun J; Tao Y; Wang S; Jiang C; Zhu Y; Yu F; Zhu J Pharmacogenomics; 2014 Mar; 15(4):487-95. PubMed ID: 24624916 [TBL] [Abstract][Full Text] [Related]
6. Reviewing pharmacogenetics to advance precision medicine for opioids. Magarbeh L; Gorbovskaya I; Le Foll B; Jhirad R; Müller DJ Biomed Pharmacother; 2021 Oct; 142():112060. PubMed ID: 34523422 [TBL] [Abstract][Full Text] [Related]
7. Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach. Escorial M; Muriel J; Agulló L; Zandonai T; Margarit C; Morales D; Peiró AM Minerva Anestesiol; 2024 May; 90(5):386-396. PubMed ID: 38619184 [TBL] [Abstract][Full Text] [Related]
8. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients. Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496 [TBL] [Abstract][Full Text] [Related]
9. The Role of Pharmacogenomics in Opioid Prescribing. Wong AK; Somogyi AA; Rubio J; Philip J Curr Treat Options Oncol; 2022 Oct; 23(10):1353-1369. PubMed ID: 36001223 [TBL] [Abstract][Full Text] [Related]
10. Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype. Wendt FR; Sajantila A; Budowle B Forensic Sci Int Genet; 2018 Mar; 33():48-58. PubMed ID: 29190510 [TBL] [Abstract][Full Text] [Related]
11. The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation. Henker RA; Lewis A; Dai F; Lariviere WR; Meng L; Gruen GS; Sereika SM; Pape H; Tarkin IS; Gowda I; Conley YP Biol Res Nurs; 2013 Jul; 15(3):309-17. PubMed ID: 22718527 [TBL] [Abstract][Full Text] [Related]
12. Review of Opioid Pharmacogenetics and Considerations for Pain Management. Owusu Obeng A; Hamadeh I; Smith M Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646 [TBL] [Abstract][Full Text] [Related]
13. Evidence Regarding Pharmacogenetics in Pain Management and Cancer. Smith DM; Figg WD Oncologist; 2023 Mar; 28(3):189-192. PubMed ID: 36718020 [TBL] [Abstract][Full Text] [Related]
14. Human Genetic Variability Contributes to Postoperative Morphine Consumption. De Gregori M; Diatchenko L; Ingelmo PM; Napolioni V; Klepstad P; Belfer I; Molinaro V; Garbin G; Ranzani GN; Alberio G; Normanno M; Lovisari F; Somaini M; Govoni S; Mura E; Bugada D; Niebel T; Zorzetto M; De Gregori S; Molinaro M; Fanelli G; Allegri M J Pain; 2016 May; 17(5):628-36. PubMed ID: 26902643 [TBL] [Abstract][Full Text] [Related]
15. Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics. Saiz-Rodríguez M; Ochoa D; Román M; Zubiaur P; Koller D; Mejía G; Abad-Santos F Pharmacogenomics; 2020 Jul; 21(10):663-675. PubMed ID: 32538291 [TBL] [Abstract][Full Text] [Related]